| 37402170 | Breast cancer PDxO cultures for drug discovery and functional precision oncology. | STAR Protoc | 2023 |
| 35221336 | A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. | Nat Cancer | 2022 |
| 36088362 | Immunologically "cold" triple negative breast cancers engraft at a higher rate in patient derived xenografts. | NPJ Breast Cancer | 2022 |
| 35941353 | Multiparametric quantitative phase imaging for real-time, single cell, drug screening in breast cancer. | Communications Biology | 2022 |
| 36619972 | Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach. | iScience | 2022 |
| 34996889 | Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment. | Nat Commun | 2022 |
| 34429404 | Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment. | Nat Commun | 2021 |
| 34104847 | Erratum: "Toward improved models of human cancer" [APL Bioeng. <b>5</b>, 010901 (2021)]. | APL Bioeng | 2021 |
| 34103681 | PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER breast cancer. | Oncogene | 2021 |
| 34027416 | Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers. | Blood Cancer Discov | 2021 |
| 33415312 | Toward improved models of human cancer. | APL Bioeng | 2021 |
| 33292639 | Protein synthesis inhibitors stimulate MondoA transcriptional activity by driving an accumulation of glucose 6-phosphate. | Cancer Metab | 2020 |
| 32046982 | ETV4 Is Necessary for Estrogen Signaling and Growth in Endometrial Cancer Cells. | Cancer Res | 2020 |
| 32816914 | STAT3 and GR Cooperate to Drive Gene Expression and Growth of Basal-Like Triple-Negative Breast Cancer. | Cancer Res | 2020 |
| 30833748 | Protective autophagy elicited by RAFâ¿¿MEKâ¿¿ERK inhibition suggests a treatment strategy for RAS-driven cancers. | Nat Med | 2019 |
| 30571086 | A Cancer-Selective Zinc Ionophore Inspired by the Natural Product Naamidine A. | ACS Chemical Biology | 2019 |
| 29539426 | Clinical and Genomic Crosstalk between Glucocorticoid Receptor and Estrogen Receptor α In Endometrial Cancer. | Cell Rep | 2018 |
| 29650789 | Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at <i>12q15</i>. | Cancer Epidemiol Biomarkers Prev | 2018 |
| 26429062 | Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential. | Breast Cancer Research | 2015 |
| 25265996 | Dioxin exposure blocks lactation through a direct effect on mammary epithelial cells mediated by the aryl hydrocarbon receptor repressor. | Toxicological Sciences | 2015 |
| 26360634 | Synthesis of Naamidine A and Selective Access to N(2)-Acyl-2-aminoimidazole Analogues. | Journal of Organic Chemistry | 2015 |
| 24767852 | Bis-aryloxadiazoles as effective activators of the aryl hydrocarbon receptor. | Bioorganic and Medicinal Chemistry Letters | 2014 |
| 25425314 | The small molecule C-6 is selectively cytotoxic against breast cancer cells and its biological action is characterized by mitochondrial defects and endoplasmic reticulum stress. | Breast Cancer Research | 2014 |
| 23456611 | Patient-derived models of human breast cancer: protocols for in vitro and in vivo applications in tumor biology and translational medicine. | Curr Protoc Pharmacol | 2013 |
| 23879992 | Development of a screen to identify selective small molecules active against patient-derived metastatic and chemoresistant breast cancer cells. | Breast Cancer Research | 2013 |
| 23212921 | Chemical genetic screen reveals a role for desmosomal adhesion in mammary branching morphogenesis. | Journal of Biological Chemistry | 2013 |
| 22138580 | TRIM29 functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer. | American Journal of Pathology | 2012 |
| 22966873 | Synthesis of the reported structures for kealiinines B and C. | Organic Letters | 2012 |
| 22425744 | On the shoulders of giants: a historical perspective of unique experimental methods in mammary gland research. | Semin Cell Dev Biol | 2012 |
| 22778488 | Synthesis and Preliminary Biological Study of Bisindolylmethanes Accessed by an Acid-Catalyzed Hydroarylation of Vinylindoles. | Tetrahedron | 2012 |
| 23486760 | Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer Subtypes. | Genes and Cancer | 2012 |
| 23144633 | Transcription factor Oct1 is a somatic and cancer stem cell determinant. | PLoS Genetics | 2012 |
| 23258598 | Overview of human primary tumorgraft models: comparisons with traditional oncology preclinical models and the clinical relevance and utility of primary tumorgrafts in basic and translational oncology research. | Curr Protoc Pharmacol | 2012 |
| 22019887 | Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. | Nat Med | 2011 |
| 21772261 | A pharmacogenomic method for individualized prediction of drug sensitivity. | Mol Syst Biol | 2011 |
| 20405356 | In situ analysis of cell populations: long-term label-retaining cells. | Methods in Molecular Biology | 2010 |
| 20486685 | Synthesis and preliminary biological studies of 3-substituted indoles accessed by a palladium-catalyzed enantioselective alkene difunctionalization reaction. | Journal of the American Chemical Society | 2010 |
| 20501844 | Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer. | Cancer Research | 2010 |
| 20405357 | Limiting-dilution transplantation assays in mammary stem cell studies. | Methods in Molecular Biology | 2010 |
| 20405358 | Use of stem cell markers in dissociated mammary populations. | Methods in Molecular Biology | 2010 |
| 20023794 | Mapping mammary gland architecture using multi-scale in situ analysis. | Integrative Biology (United Kingdom) | 2009 |
| 18371425 | Lentiviral transduction of mammary stem cells for analysis of gene function during development and cancer. | Cell Stem Cell | 2008 |
| 19048079 | Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy. | DMM Disease Models and Mechanisms | 2008 |
| 15738393 | MET and MYC cooperate in mammary tumorigenesis. | Proc Natl Acad Sci U S A | 2005 |
| 12654294 | An inducible system for the study of FGF signalling in early amphibian development. | Developmental Biology | 2003 |
| 14521513 | Isolation and characterization of functional mammary gland stem cells. | Cell Proliferation | 2003 |
| 12620994 | HIF1alpha is a critical regulator of secretory differentiation and activation, but not vascular expansion, in the mouse mammary gland. | Development (Cambridge) | 2003 |
| 14668450 | Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. | Proceedings of the National Academy of Sciences of the United States of America | 2003 |
| 14559809 | Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation. | Cancer Research | 2003 |
| 14678983 | Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice. | Cancer Research | 2003 |